[
    [
        {
            "time": "",
            "original_text": "天风证券给予华熙生物买入评级，功能性护肤品带动营收高增长超预期，业务板块全面开花锚定长期业绩",
            "features": {
                "keywords": [
                    "华熙生物",
                    "买入评级",
                    "功能性护肤品",
                    "营收高增长",
                    "业务板块全面开花",
                    "长期业绩"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "天风证券给予华熙生物买入评级，功能性护肤品带动营收高增长超预期，业务板块全面开花锚定长期业绩",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]